Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Diabetes, a disease in which carbohydrate and lipid metabolism are regulated improperly by insulin, is a serious worldwide health issue. Insulin is secreted from pancreatic beta cells in response to elevated plasma glucose, with various factors modifying its secretion. Free fatty acids (FFAs) provide an important energy source as nutrients, and they also act as signalling molecules in various cellular processes, including insulin secretion. Although FFAs are thought to promote insulin secretion in an acute phase, this mechanism is not clearly understood. Here we show that a G-protein-coupled receptor, GPR40, which is abundantly expressed in the pancreas, functions as a receptor for long-chain FFAs. Furthermore, we show that long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40. Our results indicate that GPR40 agonists and/or antagonists show potential for the development of new anti-diabetic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding and subsequent interaction of long-chain FFAs with the G-protein-coupled free fatty acid receptor (FFAR) 1 in the pancreatic β-cells leads to the activation of phospholipase C. PLC then hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) to diacylglycerol and inositol-1,4,5-triphosphate (IP3), with the latter docking on a calcium channel in the endoplasmic reticulum. The subsequent”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [94]
In the citing paper
“Activation of FFAR1 elevates [Ca2+]i and stimulates insulin secretion in a glucose-dependent fashion (306).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [306]
Citations
Cites
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,751
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · cited 1×
“MAP kinase MAP kinase activation in CHO and MIN6 cells after treatment with 10 µM of each FFA was determined as described previousl”
MethodSelf-citationCloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion
Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315
MIYAZAKI, J.-I., ARAKI, K., YAMATO, E., IKEGAMI, H., ASANO, T., SHIBASAKI, Y., OKA, Y., & YAMAMURA, K.-I. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,266
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201 · cited 1×
“Insulin is secreted from pancreatic β cells in response to elevated plasma glucose, with various factors modifying its secretio”
BackgroundThe Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104 · cited 1×
“Although it has been reported that FFAs activate GPR40 and that GPR40 is highly expressed in pancreatic β cell”
BackgroundFree Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus
BERGMAN, R., & ADER, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00323-4 · Cited by 622 · cited 1×
“: in short-term exposure, FFAs enhance GSIS but under long-term exposure they act to attenuate it; an effect called lipotoxicit”
BackgroundA prolactin-releasing peptide in the brain
Hinuma, S., Habata, Y., Fujii, R., Kawamata, Y., Hosoya, M., Fukusumi, S., Kitada, C., Masuo, Y., Asano, T., Matsumoto, H., et al. (1998) · Nature · doi:10.1038/30515 · Cited by 563 · cited 1×
“Previously, we established a strategy to identify ligands by detecting signal transductions in cells expressing orphan GPCR”
BackgroundSelf-citationMETABOLIC COUPLING FACTORS IN PANCREATIC β-CELL SIGNAL TRANSDUCTION
Newgard, C. B., & McGarry, J. D. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003353 · Cited by 531 · cited 1×
“Although several studies have proposed possible mechanisms for FFA-amplified GSIS—for example, that FFAs might simply provide energy to β cells or, alternatively, that the metabolites of FFAs, fatty acyl-coenzyme A molecules, act to stimulate insulin secretio”
BackgroundWank, S. A., Harkins, R., Jensen, R. T., Shapira, H., de Weerth, A., & Slattery, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3125 · Cited by 403 · cited 1×
“Its expression was comparable to that of type A cholecystokinin recepto”
Result
Cited by
Items 901–1,000 of 1,001
Lack of GPR40 / FFAR 1 does not induce diabetes even under insulin resistance condition
Matsuda‐Nagasumi, K., Takami‐Esaki, R., Iwachidow, K., Yasuhara, Y., Tanaka, H., Ogi, K., Nakata, M., Yano, T., Hinuma, S., Taketomi, S., et al. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12065 · Cited by 24
Self-citationGraciano, M. F. R., Leonelli, M., Curi, R., & Carpinelli, Â. R. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0509-1 · Cited by 20
MARCINAK, J. F., Cao, C., Lee, D., & Ye, Z. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13004 · Cited by 19
“GPR40 is expressed on pancreatic islet cells.(3) It is activated by long-chain free fatty acids, and consequently stimulates pancreatic β cells to secrete insulin(4,5) via a glucosedependent mechanism.”
BackgroundDiscovery of novel benzo[b]thiophene tetrazoles as non-carboxylate GPR40 agonists
Huang, H., Winters, M. P., Meegalla, S. K., Arnoult, É., Lee, S. P., Zhao, S., Martin, T., Rady, B., Liu, J., Towers, M., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.12.022 · Cited by 19
Berberine inhibits glucose oxidation and insulin secretion in rat islets
Bai, M., Liu, Y., Zhou, F., Zhang, Y., Zhu, Q., Zhang, L., Zhang, Q., Wang, S., Zhu, K., Wang, X., et al. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0543 · Cited by 19
“It has been reported that short-term exposure to physiological concentration of FFA potentiates insulin secretion [21].”
BackgroundLi, Z., Liu, C., Yang, J., Zhou, J., Ye, Z., Feng, D., Na, Y., Tong, J., Huang, W., & Qian, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.087 · Cited by 19
Overview of dietary supplements on patients with type 2 diabetes
Behrouz, V., Dastkhosh, A., & Sohrab, G. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.019 · Cited by 20
GPR120 Agonist GW9508 Ameliorated Cellular Senescence Induced by ox-LDL
Liu, R., Cheng, F., Zeng, K., Li, W., & Lan, J. (2020) · ACS Omega · doi:10.1021/acsomega.0c03581 · Cited by 20
Effects of Oligo(3-hydroxyalkanoates) on the Viability and Insulin Secretion of Murine Beta Cells
Yang, X., Zou, X., Dai, Z.-W., Luo, R., Wei, C., & Chen, G. (2009) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208x386291 · Cited by 19
All-encomPASsing regulation of β-cells: PAS domain proteins in β-cell dysfunction and diabetes
Sabatini, P. V., & Lynn, F. C. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.11.002 · Cited by 24
Soto-Guzmán, A., Villegas‐Comonfort, S., Cortés‐Reynosa, P., & Salazar, E. P. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.12.003 · Cited by 19
Nowotny, B., KAHL, S., Klüppelholz, B., Hoffmann, B. H., Giani, G., Livingstone, R. S., Nowotny, P., Stamm, V., Herder, C., Tura, A., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.12.005 · Cited by 21
Heat-regulated production and secretion of insulin from a human artificial chromosome vector
Suda, T., Katoh, M., Hiratsuka, M., Takiguchi, M., Kazuki, Y., Inoue, T., & Oshimura, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.106 · Cited by 20
Stewart, G. S., Hira, T., Higgins, A. T., Smith, C. P., & McLaughlin, J. T. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00462.2005 · Cited by 23
Bao, W., Lyu, J., Feng, G., Guo, L., Zhao, D., You, K., Liu, Y., Li, H., Du, P., Chen, D., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.027 · Cited by 18
“We used linoleic acid 37 and TAK-875 (a selective agonist of FFAR1) 38 to confirm the effect of aloe emodin on FFAR1.”
MethodTriglycerides, Glucose Metabolism, and Type 2 Diabetes
Wang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209910 · Cited by 26
“Mechanistically, palmitate and other fatty acids with chain lengths ≥ 12 carbons can bind to and activate G-protein-coupled receptor 40 (GPR40) [207,208] (Figure 17).”
Recent advances in amino acid sensing and new challenges for protein nutrition in aquaculture
Liu, C., Wang, X., Zhou, H., Mai, K., & He, G. (2019) · Marine Life Science & Technology · doi:10.1007/s42995-019-00022-1 · Cited by 18
Li, Z., Liu, C., Zhou, Z., Hu, L., Deng, L., Ren, Q., & Qian, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104679 · Cited by 18
An adipocentric perspective of pancreatic lipotoxicity in diabetes pathogenesis
Risi, R., Vidal‐Puig, A., & Bidault, G. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0313 · Cited by 19
“Therefore, it has been hypothesised that FFAR1 agonists could improve insulin secretion without increasing the risk of hypoglycaemia in patients with T2D (Kebede et al. 2008).”
BackgroundInfluentialLi, Z., Liu, C., Xu, X. J., Shi, W., Li, H., Dai, Y., Cai, X., Huang, W., & Qian, H. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.12.012 · Cited by 18
Ibrahim, W. S., Ibrahim, I. A. A. E.-H., Mahmoud, M. F., & Mahmoud, A. A. A. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420905683 · Cited by 23
“Feeding mice HFrHFD for 16 weeks induced IR and cardiac remodeling.15 Induction of IR in this model is attributed mainly to hypertriglycerdemia and increased activity of PKC with subsequent deactivation of IRS-1 leading to impaired insulin signaling.24 To maintain blood glucose levels around normal values, insulin sec…”
ResultWu, S., Cui, Z., Chen, X., Zheng, L., Ren, H., Wang, D., & Yao, J. (2021) · Journal of Dairy Science · doi:10.3168/jds.2020-18736 · Cited by 23
Acute effects of elevated NEFA on vascular function: a comparison of SFA and MUFA
Newens, K. J., Thompson, A. K., Jackson, K. G., Wright, J., & Williams, C. M. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510004976 · Cited by 21
“Both saturated and unsaturated NEFA have been shown to act directly on pancreatic b-cells to acutely increase insulin secretion in vitro; however, in vivo, the impact of NEFA on insulin depends on the prevailing glucose concentration, with a limited effect of NEFA at low glucose concentrations((42)).”
Mouillot, T., Szleper, E., Vagne, G., Barthet, S., Litime, D., Brindisi, M., Leloup, C., Pénicaud, L., Nicklaus, S., Brondel, L., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m086587 · Cited by 20
Effect of iNOS and NF-κB gene silencing on β-cell survival and function
de Paula, D., Bentley, M. V. L. B., & Mahato, R. I. (2007) · Journal of drug targeting · doi:10.1080/10611860701349695 · Cited by 18
“Indeed, gene expression has recently been silenced in b-cell lines using this technique (Itoh et al. 2003; Beeharry et al. 2004). siRNA-mediated gene therapy can be applied in several instances during the different steps of the pancreas procurement process: (i) preprocurement via intravenous…”
MethodLi, Y., Liu, Q., Pan, C., & Lan, X. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108878 · Cited by 18
Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic N-Acylethanolamines
Diep, T. A., Madsen, A. N., Krogh-Hansen, S., Al-Shahwani, M., Al-Sabagh, L., Holst, B., & Hansen, H. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100365 · Cited by 17
Fasiglifam as a new potential treatment option for patients with type 2 diabetes
Kaku, K. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.851668 · Cited by 17
“FFAs are an important energy source, and they also act as signaling molecules for modulating insulin secretion which appears to be mediated through GPR40 [25-27].”
BackgroundNakashima, R., Yano, T., Ogawa, J., Tanaka, N., Toda, N., Yoshida, M., Takano, R., Inoue, M., Honda, T., Kume, S., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.014 · Cited by 17
Ito, R., Tsujihata, Y., Suzuki, M., Miyawaki, K., Matsuda, K., & Takeuchi, K. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.230730 · Cited by 20
“GPR40/FFAR1 is a G-protein-coupled receptor highly expressed in pancreatic b -cells (Briscoe et al., 2003; Itoh et al., 2003; Kotarsky et al., 2003).”
BackgroundZhan, S., Wu, Y., Sun, P. G., Lin, H., Zhu, Y., & Han, X. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122102 · Cited by 17
“GPR40, an FFAs receptor on the islet membrane, promotes FFAs-induced insulin secretion [13].”
BackgroundInfluentialBrown, S. P., Dransfield, P. J., Vimolratana, M., Zhu, L., Luo, J., Zhang, J., Jiao, X., Pattaropong, V., Wong, S. G. W., Zhuang, R., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00213 · Cited by 17
Analysis of the Myc-induced pancreatic β cell islet tumor microenvironment using imaging ToF-SIMS
Bluestein, B. M., Morrish, F. M., Graham, D. J., Huang, L., Hockenbery, D. M., & Gamble, L. J. (2018) · Biointerphases · doi:10.1116/1.5038574 · Cited by 18
Moonwiriyakit, A., Koval, M. H., & Muanprasat, C. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.026 · Cited by 20
Physiological effects of nutrients on insulin release by pancreatic beta cells
Losada-Barragán, M. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04146-w · Cited by 23
Antibodies in metabolic diseases
Ahrens, B. (2011) · New Biotechnology · doi:10.1016/j.nbt.2011.03.022 · Cited by 20
Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathway
Ou, H., Wu, H., Lu, F., Su, Y., Hung, H., Wu, J., Yang, Y., Wu, C., & Chang, C. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0003 · Cited by 19
Ren, X., Cao, L.-Y., Zhang, J., Qin, W.-P., Yang, Y., Wan, B., & Guo, L. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00079 · Cited by 19
Bertrand, R., Wolf, A., Ivashchenko, Y., Löhn, M., Schäfer, M., Brönstrup, M., Gotthardt, M., Derdau, V., & Plettenburg, O. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00791 · Cited by 17
Combined Deletion of Free Fatty-Acid Receptors 1 and 4 Minimally Impacts Glucose Homeostasis in Mice
Croze, M. L., Guillaume, A., Éthier, M., Fergusson, G., Tremblay, C. C., Campbell, S. A., Maachi, H., Ghislain, J. J., & Poitout, V. (2021) · Endocrinology · doi:10.1210/endocr/bqab002 · Cited by 17
Long-chain fatty acid sensing in the gastrointestinal tract
McLaughlin, J. T. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351199 · Cited by 19
Katoh, K., Asari, M., Ishiwata, H., Sasaki, Y., & Obara, Y. (2003) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpb.2003.10.011 · Cited by 17
Resource allocation in mammalian systems
Baghdassarian, H. M., & Lewis, N. E. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108305 · Cited by 17
Lock, A. L., Neto, J. M. D. S., & de Souza, J. (2025) · Journal of Dairy Science · doi:10.3168/jds.2025-27040 · Cited by 19
Cloning and Characterization of Spliced Variants of the Porcine G Protein Coupled Receptor 120
Song, T., Peng, J., Ren, J., Wei, H., & Peng, J. (2015) · BioMed Research International · doi:10.1155/2015/813816 · Cited by 16
Kurtz, R., Anderman, M. F., & Shepard, B. D. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00275.2020 · Cited by 18
Factors Affecting Gut Microbiota of Puppies from Birth to Weaning
Balouei, F., Stefanon, B., Sgorlon, S., & Sandri, M. (2023) · Animals · doi:10.3390/ani13040578 · Cited by 19
“GPCR40 ( lias FFAR1) is activated by medium-chain fatty acids and long-chain fatty acids and regulates insulin secretion in pancreatic islet [123,124].”
Singh, A., Abhilasha, K. V., Acharya, K. R., Liu, H., Nirala, N. K., Parthibane, V., Govind, K., Abimannan, T., Tantalla, J., Zhu, L. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48851-8 · Cited by 19
Jabůrek, M., Klöppel, E., Průchová, P., Mozheitová, O., Tauber, J. A., Engstová, H., & Ježek, P. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103283 · Cited by 16
“Long-chain FAs (C12 – C22), both saturated and unsaturated [23 – 26], physiologically activate the G-protein-coupled receptor-40 (GPR40), i.e . the metabotropic receptor pathway [23 – 34], reportedly potentiating GSIS [16 – 19].”
Physiology and Therapeutics of the Free Fatty Acid Receptor GPR40
Huang, H., Dai, M., & Tao, Y. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00003-x · Cited by 19
Interaction of insulin with anionic phospholipid (DPPG) vesicles
Tah, B., Pal, P. K., Mishra, S., & Talapatra, G. B. (2014) · Physical Chemistry Chemical Physics · doi:10.1039/c4cp03028a · Cited by 17
Kwon, S., Joo, S. Y., Choi, H., Bae, E. H., Nam, K. I., Lee, J., & Kim, S. W. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1874 · Cited by 16
“G-protein-coupled receptor 40 (GPR40) is a member of a subfamily of G-protein-coupled receptors and is abundantly expressed in the pancreatic β -cells, where it regulates insulin secretion by functioning as a receptor for long-chain free fatty acids (10,11).”
Evaluating insulin secretagogues in a humanized mouse model with functional human islets
Luo, J., Nguyen, K., Chen, M., TRAN, T. L., Hao, J., Tian, B., Rulifson, I. C., Zhang, Y., Tian, L., Zhang, Y., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.07.010 · Cited by 17
“GPR40, which is predominantly expressed in pancreatic β cells, regulates free fatty acidinduced insulin secretion [34,35].”
BackgroundKrug, A., Vaddady, P. K., Railkar, R., Musser, B. J., Côté, J., Ederveen, A., Krefetz, D., DeNoia, E. P., Free, A. L., Morrow, L., et al. (2017) · Clinical and Translational Science · doi:10.1111/cts.12479 · Cited by 17
Ginseng Gintonin Contains Ligands for GPR40 and GPR55
Cho, Y., Choi, S.-H., Lee, R., Hwang, H., Rhim, H., Cho, I., Kim, H., Lee, J.-I., Hwang, S., & Nah, S.-Y. (2020) · Molecules · doi:10.3390/molecules25051102 · Cited by 16
“Free fatty acids, such as linoleic acid, have been known to stimulate insulin secretion by activating the fatty acid receptor GPR40/free fatty acid receptor 1 (FFAR1), which is expressed in pancreatic β cells [30,31].”
BackgroundTian, M., Wu, Z., Heng, J., Chen, F., Guan, W., & Zhang, S. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab021 · Cited by 16
Biringer, R. G. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00630-6 · Cited by 16
Chemoproteomic Analysis of Microbiota Metabolite–Protein Targets and Mechanisms
Zhao, X., Yang, X., & Hang, H. C. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00758 · Cited by 16
Yamamoto, Y., Narumi, K., Yamagishi, N., Nishi, T., Ito, T., Iseki, K., Kobayashi, M., & Kanai, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1197743 · Cited by 17
Self-citationYang, M. J., Chisholm, J. W., Soelaiman, S., & Shryock, J. C. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.033 · Cited by 19
Tonack, S., Tang, C., & Offermanns, S. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00641.2012 · Cited by 21
“Activation of FFA1 by fatty acids on -cells stimulates insulin secretion in a concentration-dependent manner (64), and, in addition, Edfalk et al.”
Li, Z., Xu, X., Li, G., Fu, X., Liu, Y., Feng, Y., Wang, M., Ouyang, Y., & Han, J. D. J. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.10.040 · Cited by 16
Effect of omega-3 fatty acids on glucose homeostasis: role of free fatty acid receptor 1
El‐Fayoumi, S. H., Mahmoud, A. A. A., Fahmy, A., & Ibrahim, I. A. A. E.-H. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01883-5 · Cited by 17
“FFAR1, also known as GPR40, is preferentially expressed in pancreatic β cells and to a lesser extent in peripheral tissues (Itoh et al. 2003).”
BackgroundAddressing free fatty acid receptor 1 (FFAR1) activation using supervised molecular dynamics
Atanasio, S., Deganutti, G., & Reynolds, C. A. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00338-6 · Cited by 19
Takamura, M., Sakurai, M., Yamada, E., Fujita, S., Yachi, M., Takagi, T., Isobe, A., Hagisawa, Y., Fujiwara, T., & Yanagisawa, H. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.01.048 · Cited by 16
Fujiwara, K., Maekawa, F., Dezaki, K., Nakata, M., Yashiro, T., & Yada, T. (2007) · Endocrinology · doi:10.1210/en.2006-1156 · Cited by 21
Modelling of energy-driven switch for glucagon and insulin secretion
Grubelnik, V., Zmazek, J., Markovič, R., Gosak, M., & Marhl, M. (2020) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2020.110213 · Cited by 15
G-protein-coupled receptor 84 regulates acute inflammation in normal and diabetic skin wounds
Cooper, P. O., Kleb, S. S., Noonepalle, S. K. R., Amuso, V. M., Varshney, R., Rudolph, M. C., Dhaliwal, T. K., Nguyen, D. V., Mazumder, M. F., Babirye, N. S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114288 · Cited by 17
Agunloye, M. O., Owu, D. U., Onaadepo, O., Bisong, S. A., Ogunyemi, O. M., & Ugwu, F. N. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01551-y · Cited by 17
Optimization of 3-aryl-3-ethoxypropanoic acids and discovery of the potent GPR40 agonist DS-1558
Takano, R., Yoshida, M., Inoue, M., Honda, T., Nakashima, R., Matsumoto, K., Yano, T., Ogata, T., Watanabe, N., Hirouchi, M., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.028 · Cited by 16
Guo, D.-Y., Li, D., Ning, M., Dang, X.-Y., Zhang, L., Zeng, L.-M., Hu, Y., & Leng, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.130 · Cited by 16
Ishii, S., Kitamura, Y., Hirane, M., Tomimatsu, A., Fukushima, K., Takahashi, K., Fukushima, N., Honoki, K., & Tsujiuchi, T. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22408 · Cited by 15
Variants in the FFAR1 Gene Are Associated with Beta Cell Function
Kalis, M., Levéen, P., Lyssenko, V., Almgren, P., Groop, L., & Cilio, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001090 · Cited by 15
Bone marrow-derived stromal cells can express neuronal markers by DHA/GPR40 signaling.
Kaplamadzhiev, D. B., Hisha, H., Adachi, Y., Ikehara, S., Tonchev, A. B., Boneva, N. B., Pyko, I. V., Kikuchi, M., Nakaya, M., Wakayama, T., et al. (2010) · PubMed · Cited by 21
Krasavin, M., Lukin, A. Y., Zhurilo, N., Kovalenko, A. L., Zahanich, I., & Zozulya, S. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1142984 · Cited by 15
“N(1)–(2-methylphenyl)-2-hydrazino-2-thiooxacetamide (7i) Yield 73%, yellow solid, m.”
InfluentialKakei, M., Yoshida, M., Dezaki, K., Ito, K., Yamada, H., Funazaki, S., Kawakami, M., Sugawara, H., & Yada, T. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0262 · Cited by 16
Tsuda, N., Kawaji, A., Sato, T., Takagi, M., Higashi, C., Kato, Y., Ogawa, K., Naba, H., Ohkouchi, M., Nakamura, M., et al. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.340 · Cited by 18
“G protein-coupled receptor 40/Free fatty acid receptor 1 (GPR40/FFAR1) is highly expressed in pancreatic b-cells and can be activated by medium- to long-chain free fatty acids (FFAs) (Briscoe et al. 2003; Itoh et al. 2003; Kotarsky et al. 2003).”
BackgroundStructural basis for the agonist action at free fatty acid receptor 1 (FFA1R or GPR40)
Rodrigues, D. A., Pinheiro, P. D. S. M., Ferreira, T. T. S. C., Thota, S., & Fraga, C. A. M. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13131 · Cited by 15
Velasco, C., Conde‐Sieira, M., Comesaña, S., Chivite, M., Díaz-Rúa, A., Míguez, J. M., & Soengas, J. L. (2020) · Journal of Experimental Biology · doi:10.1242/jeb.227330 · Cited by 20
“Activation of extracellular signal regulated kinases (ERK1/2) has been confirmed as one of the downstream signalling cascades of FFAR1- and FFA4-Gαq protein signalling (Itoh et al., 2003; Katsuma et al., 2005).”
BackgroundOmega 3 fatty acids stimulate thermogenesis during torpor in the Arctic Ground Squirrel
Rice, S. A., Mikes, M. L., Bibus, D. M., Berdyshev, E. V., Reisz, J. A., Gehrke, S. A., Bronova, I. A., D’Alessandro, A., & Drew, K. L. (2021) · Scientific Reports · doi:10.1038/s41598-020-78763-8 · Cited by 21
Discovery and development of CPL207280 as new GPR40/FFA1 agonist
Mach, M., Bazydło‐Guzenda, K., Buda, P., Matłoka, M., Dzida, R., Stelmach, F., Gałązka, K., Wąsińska-Kałwa, M., Smuga, D. A., Hołowińska, D., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113810 · Cited by 15
Zhou, Z., Ren, Q., Jiao, S., Cai, Z., Geng, X., Deng, L., Wang, B., Hu, L., Zhang, L., Yang, Y., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114061 · Cited by 16
Modulation of inflammatory and immune responses by short-chain fatty acids
Vinolo, M. A. R., Rodrigues, H. G., Nachbar, R. T., & Curi, R. (2013) · Elsevier eBooks · doi:10.1533/9780857095749.3.435 · Cited by 19
In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469
Urban, C., Hamacher, A., Partke, H.-J., Roden, M., Schinner, S., Christiansen, E., Due‐Hansen, M. E., Ulven, T., Gohlke, H., & Kassack, M. U. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0899-3 · Cited by 16
Shrimal, S., Saha, A., Bhattacharya, S., & Bhattacharya, A. (2012) · Scientific Reports · doi:10.1038/srep00333 · Cited by 15
“Free fatty acid receptors have been identified in pancreatic beta cells and these have been implicated in regulation of insulin secretio”
BackgroundZhou, Y.-J., Song, Y., Zhou, H., & Yan, L. (2012) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(12)60017-0 · Cited by 19
Lipid Signalling Dynamics at the β‐cell Plasma Membrane
Wuttke, A. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12369 · Cited by 16
Mazuy, C., Ploton, M., Eeckhoute, J., Berrabah, W., Staels, B., Lefèbvre, P., & Helleboid‐Chapman, A. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.10.024 · Cited by 16
“Triglyceride storage, reactive oxygen species production, dysregulation of the glucose metabolic pathway [7] and GPR40 FFA membrane receptor activation [8] are involved in FFA-induced GSIS inhibition.”
BackgroundFeng, D.-D., Zhao, Y.-F., Luo, Z., Keating, D. J., & Chen, C. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0426 · Cited by 15
Neuman, J. C., Fenske, R. J., & Kimple, M. E. (2016) · Nutrition and Healthy Aging · doi:10.3233/nha-160004 · Cited by 15
“[33] Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, et al.”
BackgroundMoonwiriyakit, A., Wattanaphichet, P., Chatsudthipong, V., & Muanprasat, C. (2018) · Tissue Barriers · doi:10.1080/21688370.2018.1480741 · Cited by 17
Kato, S., Utsumi, D., & Matsumoto, K. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.05.003 · Cited by 15
Rani, L., Grewal, A. S., Sharma, N., & Singh, S. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666201023141326 · Cited by 15
Recent developments in natural products for white adipose tissue browning
Ma, P., He, P., Xu, C., Hou, B., Qiang, G., & Du, G. (2020) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(20)60021-8 · Cited by 15
“Another study showed WAT delipidation and browning effect on retroperitoneal WAT after feeding male C57BL/6JNarl mice with bitter melon seed oil (BMSO) [77].”
BackgroundInfluential4-CMTB Ameliorates Ovalbumin-Induced Allergic Asthma through FFA2 Activation in Mice
Lee, J., & Im, D. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2020.176 · Cited by 15
Zhao, Y.-F., Feng, D., Hernandez, M., & Chen, C. (2007) · Endocrine · doi:10.1007/s12020-007-0001-3 · Cited by 17
Cataldo, L. R., Mizgier, M. L., Busso, D., Olmos, P. R., Galgani, J. E., Valenzuela, R., Mezzano, D., Aranda, E., Cortés, V., & Santos, J. L. (2016) · Journal of Diabetes Research · doi:10.1155/2016/3793781 · Cited by 22
Pyo, H., An, X., & Cho, H. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30826 · Cited by 15
“FFAR1 is expressed in pancreatic β‐cells where it mediates insulin secretion (Alquier et al., 2009; Itoh et al., 2003).”
BackgroundZhao, X., Ahn, D., Nam, G., Kwon, J., Song, S.-Y., Kang, M. J., Ahn, H., & Chung, S. J. (2023) · Nutrients · doi:10.3390/nu15224774 · Cited by 14
“It has been shown that endogenous ligands or synthetic agonists control the release of insulin in a glucose-dependent way, contrary to insulin, sulfonylureas, and other widely used drugs, having minimal risk of hypoglycemia or other side effects [3–5].”
ResultG protein-coupled receptors and obesity
Pocai, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1301017 · Cited by 16
Metadata
- Authors
- Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., Tanaka, H., Maruyama, M., Satoh, R., Okubo, S., Kizawa, H., Komatsu, H., Matsumura, F., Noguchi, Y., Shinohara, T., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- ORCID
- Venue
- Nature
- Published
- 2003-02-23
- Volume
- 422
- Issue
- 6928
- Pages
- 173-176
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2128326754
- Cited by
- 1,538
- References
- 26
- Citations by year
- 2026: 21 · 2025: 50 · 2024: 54 · 2023: 51 · 2022: 58 · 2021: 89 · 2020: 74 · 2019: 75 · 2018: 88 · 2017: 89 · 2016: 111 · 2015: 82 · 2014: 84 · 2013: 91 · 2012: 84
- FWCI
- 45.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- free fatty acids, GPR40, insulin secretion, pancreatic beta cells, glucose-stimulated insulin secretion, long-chain fatty acids, G protein-coupled receptors, diabetes mellitus, antidiabetic drug development
- MeSH terms
- Insulin Secretion, Animals, Haplorhini, Calcium, Enzyme Activation, Fatty Acids, Nonesterified, Glucose, Cricetinae, Humans, Insulin, Male, Molecular Sequence Data, Pancreas, Receptors, Cell Surface, RNA, Messenger, Transfection, CHO Cells, Rats, Wistar, Calcium Signaling, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, RNA, Small Interfering, Receptors, G-Protein-Coupled, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.